Yusuke Nakamura

Yusuke Nakamura

NIBIOHN, JFCR, U of Chicago, U of Tokyo, RIKEN, Cancer Institute, Univ. of Utah, Osaka …
Correu electrònic verificat a jfcr.or.jp
Citat per 232387
Cancer Genomics Genetics Precision Medicine Drug Development
Maciej Banach

Maciej Banach

Vice-Rector for Faculty of Medicine, KUL; President, International Lipid Expert Panel, Poland
Correu electrònic verificat a umed.lodz.pl
Citat per 181023
Atherosclerosis Lipids Preventive Cardiology Drug Development Cardiovascular Disease
Aroon Hingorani

Aroon Hingorani

University College London
Correu electrònic verificat a ucl.ac.uk
Citat per 162380
Genomics drug development cardiovascular diseases multi-morbidity
Jaap Verweij

Jaap Verweij

Erasmus University Medical Center and Cancer Drug Development Forum
Correu electrònic verificat a cddf.org
Citat per 126906
Drug development Sarcomas
john C. Byrd

john C. Byrd

Distinguished University Professor, The Ohio State University
Correu electrònic verificat a osumc.edu
Citat per 115285
Hematology Drug Development
Alexander EGGERMONT

Alexander EGGERMONT

Princess Maxima Center & University Medical Center Utrecht, Netherlands alexander …
Correu electrònic verificat a prinsesmaximacentrum.nl
Citat per 113199
oncology immunotherapy drug development
Jean-Charles Soria

Jean-Charles Soria

Amgen R&D
Correu electrònic verificat a amgen.com
Citat per 113170
oncology drug development molecular biology precision medecine lung cancer
Matthew J. Ellis

Matthew J. Ellis

Guardant Health Palo Alto CA
Correu electrònic verificat a guardanthealth.com
Citat per 91856
drug development precision medicine breast cancer cancer genomics cancer proteomics
David A Collier

David A Collier

Independent Consultant
Correu electrònic verificat a kcl.ac.uk
Citat per 87716
psychosis neurodegeneration bioinformatics genomics drug development
Richard Mohs

Richard Mohs

Global Alzheimer's Platform Foundation
Correu electrònic verificat a globalalzplatform.org
Citat per 79768
neuroscience psychology drug development
1 - 10